Cohance Lifesciences (NSE:COHANCE) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:COHANCE Cohance Lifesciences Ltd NSE:COHANCE
82 GF Score
Price ₹455.95
GF Value ₹798.35
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Cohance Lifesciences FFO?

FFO (Funds from operations) only applies to REITs.

NSE:COHANCE
82GF Score
Cohance Lifesciences Ltd NSE:COHANCE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cohance Lifesciences (NSE:COHANCE) Overvalued in 2026?

Based on GuruFocus' analysis, Cohance Lifesciences stock appears to be undervalued. The current stock price of ₹455.95 is trading 42.9% below its estimated GF Value™ of ₹798.35. GuruFocus considers Cohance Lifesciences to be Significantly Undervalued.

Key valuation signals for NSE:COHANCE:

  • FFO:
  • GF Value™: ₹798.35 vs. price of ₹455.95 (42.9% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the NSE:COHANCE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cohance Lifesciences Business Description

Other Exchanges 543064:India
Address Hitech City Road, Panmaktha Plot, 1, 202, 2nd Floor, B-Wing, Galaxy by Aurobindo Realty, Sy No 83/1, Hyderabad Knowledge City TSIIC Raidurg, Opposite IKEA, Hyderabad, TG, IND, 500081
Cohance Lifesciences Ltd is a CDMO and API platform, offering products and services across all phases of a molecule's lifecycle from development to commercialization. Its Business Units comprise: CDMO, API+ and Formulations, and Clinical and Analytical Services.
82GF Score

Get the complete analysis for NSE:COHANCE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹455.95
Price
₹798.35
GF Value